Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity

T. Pertseva (Dnipropetrovsk, Ukraine), D. Koval (Dnipropetrovsk, Ukraine)

Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Session: COPD and the impact of comorbidities
Session type: E-poster session
Number: 2472
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Pertseva (Dnipropetrovsk, Ukraine), D. Koval (Dnipropetrovsk, Ukraine). Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity. 2472

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Relationship between level of transforming growth factor beta 1 (TGF beta 1) and serum amyloid A in COPD patients
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 92s
Year: 2001

Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

Transforming growth factor beta (TGFβ)-2 and -3 gene polymorphisms in different phenotypes of sarcoidosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Expression of basic fibroblast growth factor (bFGF) in smokers with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004

Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006

Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis
Source: Eur Respir J 2011; 37: 169-175
Year: 2011



Transforming growth factor beta-1 gene polymorphisms and course of asthma
Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma
Year: 2011

Transforming growth factor-beta1 (TGF-beta1) gene polymorphism in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006

The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006



Transforming growth factor beta (TGF-ß) pathway activation by IPF fibroblast-derived soluble factors is mediated by IL-6 trans-signaling
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


Transforming growth factor (TGF)-b1 gene common polymorphisms and plasma TGF-b1 levels in patients with lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 435s
Year: 2005

Transforming growth factor β in induced sputum and whole blood in cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005

Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 573s
Year: 2003

Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM).
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019


Transforming growth factor beta induces Beclin-1 in pulmonary arterial endothelial cells
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008